Challenges in Sub-Saharan Africa's Oncology Trials π
Dr. Abioye discusses barriers to clinical trial participation in sub-Saharan Africa, highlighted at ASCO 2025, impacting cancer care quality.

ecancer
7 views β’ Aug 28, 2025

About this video
Dr Oyepeju Folashade Abioye talks to ecancer about a study she presented at ASCO 2025.
Access to clinical trials remains a pillar of high-quality cancer care. Oncology research in sub-Saharan Africa is hindered by multifaceted barriers, limiting the development of effective, region-specific therapies.Β
Strategies to address these barriers include investing in the training of healthcare professionals, providing adequate infrastructure, increasing funding through public-private partnerships, and enhancing community engagement to build trust and improve trial participation.
Access to clinical trials remains a pillar of high-quality cancer care. Oncology research in sub-Saharan Africa is hindered by multifaceted barriers, limiting the development of effective, region-specific therapies.Β
Strategies to address these barriers include investing in the training of healthcare professionals, providing adequate infrastructure, increasing funding through public-private partnerships, and enhancing community engagement to build trust and improve trial participation.
Tags and Topics
Browse our collection to discover more content in these categories.
Video Information
Views
7
Duration
4:52
Published
Aug 28, 2025
Related Trending Topics
LIVE TRENDSRelated trending topics. Click any trend to explore more videos.
Trending Now